Latest Breaking News On - Edison group us investor relations - Page 2 : comparemela.com

Biodexa Appoints Ann Merchant to the Board of Directors

Biodexa Pharmaceuticals PLC Biodexa Appoints Ann Merchant to the Board of Directors CARDIFF, United Kingdom, Dec. 29, 2023 – Biodexa Pharmaceuticals PLC , a clinical stage biopharmaceutical.

United kingdomSchreiner medipharmStephen parkerGlobenewswire incBoard of directors the company asHead of international supply chainBiodexa pharmaceuticalsEdison group us investor relationsHenley business schoolGeorgetown universityAppoints ann merchantNon executive directorVice presidentGlobal supply chainInternational supply chainSite head

Biodexa Pharmaceuticals (BDRX) to Acquire Exclusive Worldwide License to Tolimidone

Biodexa Pharmaceuticals (BDRX) to Acquire Exclusive Worldwide License to Tolimidone
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJean buteauAlberta diabetes instituteBukwang pharmaceutical coBiodexa pharmaceuticalsCompany american depositryEdison group us investor relationsMelior pharmaceuticalsi incNational library of medicineAdhera therapeutics incPfizer incUniversity of albertaAdhera therapeuticsStephen stampProfessor jean buteau

Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma

Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDmitry zamoryakhinBiodexa pharmaceuticalsBiodexa ltdAmerican medical associationEuropean union withdrawalEdison group us investor relationsCompletes recruitmentRecurrent glioblastomaData safety monitoring boardTemozolomide aloneRandomized clinicalAmerican medicalEuropean unionPrivate securities litigation reform act

Interim results for the six months ended 30 June 2023

Interim results for the six months ended 30 June 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomMonte carloBiodexa kpisAdss of the companyEdison group us investor relationsCompany ordinaryInternational accounting standardsExchange commissionUniversity of texasArmistice capital master fund ltdDuke universityBiosciences incBaptist md anderson cancer centerColumbia universityInternational financial reporting standardsInternational accounting standards board

Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement

Biodexa Pharmaceuticals PLC Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement Biodexa Pharmaceuticals PLC , a clinical-stage biopharmaceutical company developing a pipeline of.

United statesUnited kingdomNasdaq hearing panelBiodexa pharmaceuticalsNasdaq hearings panelGlobenewswire incEdison group us investor relationsNasdaq stock marketRegain complianceBid priceHearing panelMandatory panel monitorListing qualifications staffPrivate securities litigation reform act